Methylphenidate hydrochloride 5 MG Oral Tablet — RxCUI 1091497
RxNorm drug concept · Semantic clinical drug
RxCUI 1091497
Semantic clinical drug · SCD
● Current RxNorm concept 48 FDA products
73 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1091497
Official nameMethylphenidate hydrochloride 5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmethylphenidate HCl 5 MG Oral Tablet
FDA products mapped48
Package NDCs mapped73
Reported Medicaid activity (SDUD)1,308,749 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Methylphenidate Transdermal Patch: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Yes, location matters. Apply the patch to the hip area — not the waist, arm, or back. The clinical studies that established how well and how safely the patch works were done specif...
- Where exactly do I put the patch and does it matter?
- Water exposure — from bathing, swimming, or showering — can affect how well the patch sticks. If the patch partially or fully comes off, don't try to re-stick it with tape or adhes...
- Can my child shower or swim while wearing the patch?
🕸️ Concept Web — How Methylphenidate hydrochloride 5 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Methylphenidate hydrochloride 5 MG Oral Tablet
RxCUI 1091497 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Methylphenidate
6901IN -
Methylphenidate hydrochloride
203188PIN
-
Methylphenidate
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Ritalin
224917BN
-
Ritalin
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Methylphenidate Oral Tablet
372861SCDF -
Methylphenidate hydrochloride Oral Tablet
2647048SCDFP -
Methylphenidate Oral Product
1163482SCDG -
Methylphenidate Pill
1163483SCDG -
Methylphenidate hydrochloride Oral Product
2661865SCDGP -
Methylphenidate hydrochloride Pill
2659123SCDGP -
Methylphenidate Oral Tablet [Ritalin]
368776SBDF -
Methylphenidate hydrochloride Oral Tablet [Ritalin]
2654306SBDFP - +5 more in this family
-
Methylphenidate Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Methylphenidate hydrochloride 5 MG
1091321SCDC -
Methylphenidate hydrochloride 5 MG Oral Tablet [Ritalin]
1091500SBD -
Methylphenidate hydrochloride 5 MG [Ritalin]
1091499SBDC
-
Methylphenidate hydrochloride 5 MG
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Methylphenidate hydrochloride 5 MG
SCDC · 1091321 -
Methylphenidate Oral Tablet
SCDF · 372861 -
Methylphenidate hydrochloride Oral Tablet
SCDFP · 2647048 -
Methylphenidate Oral Product
SCDG · 1163482 -
Methylphenidate Pill
SCDG · 1163483 -
Methylphenidate hydrochloride Oral Product
SCDGP · 2661865 -
Methylphenidate hydrochloride Pill
SCDGP · 2659123
Brand-Name Concepts
-
Methylphenidate hydrochloride 5 MG Oral Tablet [Ritalin]
SBD · 1091500 -
Methylphenidate hydrochloride 5 MG [Ritalin]
SBDC · 1091499 -
Methylphenidate Oral Tablet [Ritalin]
SBDF · 368776 -
Methylphenidate hydrochloride Oral Tablet [Ritalin]
SBDFP · 2654306 -
Ritalin Oral Product
SBDG · 1185343 -
Ritalin Pill
SBDG · 1185344 -
Ritalin
BN · 224917
📦 FDA Products & Package NDCs
48 products · 73 package NDCs
73 package NDCs map to RxCUI 1091497 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00078-0439-05 | 100 TABLET in 1 BOTTLE (0078-0439-05) | Ritalin | Novartis Pharmaceuticals Corporation | 1955-12-31 |
| 00078-0440-05 | 100 TABLET in 1 BOTTLE (0078-0440-05) | Ritalin | Novartis Pharmaceuticals Corporation | 1955-12-31 |
| 00078-0441-05 | 100 TABLET in 1 BOTTLE (0078-0441-05) | Ritalin | Novartis Pharmaceuticals Corporation | 1955-12-31 |
| 00115-1800-01 | 100 TABLET in 1 BOTTLE, PLASTIC (0115-1800-01) | METHYLPHENIDATE HYDROCHLORIDE | Amneal Pharmaceuticals of New York LLC | 2014-04-07 |
| 00115-1801-01 | 100 TABLET in 1 BOTTLE, PLASTIC (0115-1801-01) | METHYLPHENIDATE HYDROCHLORIDE | Amneal Pharmaceuticals of New York LLC | 2014-04-07 |
| 00115-1802-01 | 100 TABLET in 1 BOTTLE, PLASTIC (0115-1802-01) | METHYLPHENIDATE HYDROCHLORIDE | Amneal Pharmaceuticals of New York LLC | 2014-04-07 |
| 00406-1142-01 | 100 TABLET in 1 BOTTLE (0406-1142-01) | Methylphenidate Hydrochloride | SpecGx LLC | 1998-11-27 |
| 00406-1142-10 | 1000 TABLET in 1 BOTTLE (0406-1142-10) | Methylphenidate Hydrochloride | SpecGx LLC | 1998-11-27 |
| 00406-1144-01 | 100 TABLET in 1 BOTTLE (0406-1144-01) | Methylphenidate Hydrochloride | SpecGx LLC | 1998-11-27 |
| 00406-1144-10 | 1000 TABLET in 1 BOTTLE (0406-1144-10) | Methylphenidate Hydrochloride | SpecGx LLC | 1998-11-27 |
| 00406-1146-01 | 100 TABLET in 1 BOTTLE (0406-1146-01) | Methylphenidate Hydrochloride | SpecGx LLC | 1998-11-27 |
| 00406-1146-10 | 1000 TABLET in 1 BOTTLE (0406-1146-10) | Methylphenidate Hydrochloride | SpecGx LLC | 1998-11-27 |
| 10702-0100-01 | 100 TABLET in 1 BOTTLE (10702-100-01) | Methylphenidate Hydrochloride | KVK-TECH, INC. | 2017-05-11 |
| 10702-0101-01 | 100 TABLET in 1 BOTTLE (10702-101-01) | Methylphenidate Hydrochloride | KVK-TECH, INC. | 2017-05-11 |
| 10702-0102-01 | 100 TABLET in 1 BOTTLE (10702-102-01) | Methylphenidate Hydrochloride | KVK-TECH, INC. | 2017-05-11 |
| 13107-0380-01 | 100 TABLET in 1 BOTTLE (13107-380-01) | Methylphenidate Hydrochloride | Aurolife Pharma, LLC | 2017-04-11 |
| 13107-0381-01 | 100 TABLET in 1 BOTTLE (13107-381-01) | Methylphenidate Hydrochloride | Aurolife Pharma, LLC | 2017-04-11 |
| 13107-0382-01 | 100 TABLET in 1 BOTTLE (13107-382-01) | Methylphenidate Hydrochloride | Aurolife Pharma, LLC | 2017-04-11 |
| 16729-0478-01 | 100 TABLET in 1 BOTTLE (16729-478-01) | METHYLPHENIDATE HYDROCHLORIDE | Accord Healthcare, Inc. | 2020-12-23 |
| 16729-0479-01 | 100 TABLET in 1 BOTTLE (16729-479-01) | METHYLPHENIDATE HYDROCHLORIDE | Accord Healthcare, Inc. | 2020-12-17 |
| 16729-0480-01 | 100 TABLET in 1 BOTTLE (16729-480-01) | METHYLPHENIDATE HYDROCHLORIDE | Accord Healthcare, Inc. | 2020-12-17 |
| 31722-0173-01 | 100 TABLET in 1 BOTTLE (31722-173-01) | METHYLPHENIDATE HYDROCHLORIDE | Camber Pharmaceutical Inc | 2015-10-01 |
| 31722-0173-05 | 500 TABLET in 1 BOTTLE (31722-173-05) | METHYLPHENIDATE HYDROCHLORIDE | Camber Pharmaceutical Inc | 2015-10-01 |
| 31722-0174-01 | 100 TABLET in 1 BOTTLE (31722-174-01) | METHYLPHENIDATE HYDROCHLORIDE | Camber Pharmaceutical Inc | 2015-10-01 |
| 31722-0174-05 | 500 TABLET in 1 BOTTLE (31722-174-05) | METHYLPHENIDATE HYDROCHLORIDE | Camber Pharmaceutical Inc | 2015-10-01 |
| 31722-0175-01 | 100 TABLET in 1 BOTTLE (31722-175-01) | METHYLPHENIDATE HYDROCHLORIDE | Camber Pharmaceutical Inc | 2015-10-01 |
| 31722-0175-05 | 500 TABLET in 1 BOTTLE (31722-175-05) | METHYLPHENIDATE HYDROCHLORIDE | Camber Pharmaceutical Inc | 2015-10-01 |
| 43386-0573-01 | 100 TABLET in 1 BOTTLE (43386-573-01) | Methylphenidate Hydrochloride | Lupin Pharmaceuticals,Inc. | 2016-01-20 |
| 43386-0574-01 | 100 TABLET in 1 BOTTLE (43386-574-01) | Methylphenidate Hydrochloride | Lupin Pharmaceuticals,Inc. | 2016-01-20 |
| 43386-0575-01 | 100 TABLET in 1 BOTTLE (43386-575-01) | Methylphenidate Hydrochloride | Lupin Pharmaceuticals,Inc. | 2016-01-20 |
| 43547-0486-10 | 100 TABLET in 1 BOTTLE (43547-486-10) | Methylphenidate hydrochloride | Solco Healthcare US,LLC | 2020-07-01 |
| 43547-0487-10 | 100 TABLET in 1 BOTTLE (43547-487-10) | Methylphenidate hydrochloride | Solco Healthcare US,LLC | 2020-07-01 |
| 43547-0488-10 | 100 TABLET in 1 BOTTLE (43547-488-10) | Methylphenidate hydrochloride | Solco Healthcare US,LLC | 2020-07-01 |
| 57664-0228-08 | 100 TABLET in 1 BOTTLE (57664-228-08) | Methylphenidate Hydrochloride | Sun Pharmaceutical Industries, Inc. | 2013-08-16 |
| 57664-0228-13 | 500 TABLET in 1 BOTTLE (57664-228-13) | Methylphenidate Hydrochloride | Sun Pharmaceutical Industries, Inc. | 2013-08-16 |
| 57664-0228-18 | 1000 TABLET in 1 BOTTLE (57664-228-18) | Methylphenidate Hydrochloride | Sun Pharmaceutical Industries, Inc. | 2013-08-16 |
| 57664-0228-83 | 30 TABLET in 1 BOTTLE (57664-228-83) | Methylphenidate Hydrochloride | Sun Pharmaceutical Industries, Inc. | 2013-08-16 |
| 57664-0228-88 | 100 TABLET in 1 BOTTLE (57664-228-88) | Methylphenidate Hydrochloride | Sun Pharmaceutical Industries, Inc. | 2013-08-16 |
| 57664-0229-08 | 100 TABLET in 1 BOTTLE (57664-229-08) | Methylphenidate Hydrochloride | Sun Pharmaceutical Industries, Inc. | 2013-08-16 |
| 57664-0229-13 | 500 TABLET in 1 BOTTLE (57664-229-13) | Methylphenidate Hydrochloride | Sun Pharmaceutical Industries, Inc. | 2013-08-16 |
| 57664-0229-18 | 1000 TABLET in 1 BOTTLE (57664-229-18) | Methylphenidate Hydrochloride | Sun Pharmaceutical Industries, Inc. | 2013-08-16 |
| 57664-0229-83 | 30 TABLET in 1 BOTTLE (57664-229-83) | Methylphenidate Hydrochloride | Sun Pharmaceutical Industries, Inc. | 2013-08-16 |
| 57664-0229-88 | 100 TABLET in 1 BOTTLE (57664-229-88) | Methylphenidate Hydrochloride | Sun Pharmaceutical Industries, Inc. | 2013-08-16 |
| 57664-0230-08 | 100 TABLET in 1 BOTTLE (57664-230-08) | Methylphenidate Hydrochloride | Sun Pharmaceutical Industries, Inc. | 2013-08-16 |
| 57664-0230-13 | 500 TABLET in 1 BOTTLE (57664-230-13) | Methylphenidate Hydrochloride | Sun Pharmaceutical Industries, Inc. | 2013-08-16 |
| 57664-0230-18 | 1000 TABLET in 1 BOTTLE (57664-230-18) | Methylphenidate Hydrochloride | Sun Pharmaceutical Industries, Inc. | 2013-08-16 |
| 57664-0230-83 | 30 TABLET in 1 BOTTLE (57664-230-83) | Methylphenidate Hydrochloride | Sun Pharmaceutical Industries, Inc. | 2013-08-16 |
| 57664-0230-88 | 100 TABLET in 1 BOTTLE (57664-230-88) | Methylphenidate Hydrochloride | Sun Pharmaceutical Industries, Inc. | 2013-08-16 |
| 63629-1172-01 | 100 TABLET in 1 BOTTLE (63629-1172-1) | Methylphenidate Hydrochloride | Bryant Ranch Prepack | 2013-08-16 |
| 66758-0273-01 | 100 TABLET in 1 BOTTLE (66758-273-01) | Ritalin | Sandoz Inc | 2025-07-28 |
Observed labelers:
Sun Pharmaceutical Industries, Inc. (15) ·
Ascend Laboratories, LLC (6) ·
Camber Pharmaceutical Inc (6) ·
SpecGx LLC (6) ·
XLCare Pharmaceuticals Inc (6) ·
Bryant Ranch Prepack (5)
· +10 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.